For someone living with schizophrenia, the world can feel fundamentally unreliable. The disconnect from reality—often manifesting as hallucinations or delusions—is frequently accompanied by a profound cognitive struggle: the inability to integrate new information to update one’s understanding of the environment. This mental rigidity can make simple decision-making an arduous task and may contribute to the persistent detachment from reality that characterizes the disorder.
New research from MIT has identified a specific gene mutation in schizophrenia that may be responsible for this cognitive “trap.” By studying the biological machinery of the brain, researchers discovered that a mutation in the grin2a gene disrupts a critical circuit responsible for updating beliefs when new evidence is presented. Essentially, the brain becomes unable to let go of an classic “truth” even when the current reality proves it wrong.
The study, published in Nature Neuroscience, suggests that this dysfunction is not just a symptom of the disorder, but a primary mechanism of its pathology. By identifying the exact brain region affected, the team has opened a potential door for new pharmacological treatments targeting cognitive impairment, which has historically been one of the most difficult aspects of schizophrenia to treat.
The Genetic Architecture of Psychosis
Schizophrenia is known to have a powerful genetic component, though it rarely stems from a single “broken” gene. In the general population, the prevalence of the condition is approximately 1 percent. However, that risk climbs to 10 percent for those with an affected parent or sibling and reaches as high as 50 percent for identical twins.
For years, scientists at the Broad Institute of MIT and Harvard have used genome-wide association studies to locate clues. While they identified over 100 gene variants linked to the disorder, many were located in “non-coding” regions of DNA—areas that do not provide instructions for making proteins—making them difficult to interpret.
To get a clearer picture, the research team shifted to whole-exome sequencing, a method that looks specifically at the protein-coding regions of the genome. By analyzing the sequences of roughly 25,000 people with schizophrenia and 100,000 control subjects, they pinpointed 10 genes where mutations significantly increased the risk of developing the disorder. One of these was grin2a.
Trapped by Prior Beliefs
The grin2a gene is responsible for producing part of the NMDA receptor, a protein activated by the neurotransmitter glutamate. These receptors are essential for synaptic plasticity—the brain’s ability to strengthen or weaken connections based on experience.
Tingting Zhou, a research scientist at the McGovern Institute and lead author of the study, explains that the brain operates on a system of “prior beliefs.” In a neurotypical brain, when new sensory information arrives, the brain uses that input to update the prior belief, creating a new understanding that aligns with reality.
“What happens in schizophrenia patients is that they weigh too heavily on the prior belief. They don’t use as much current input to update what they believed before, so the new belief is detached from reality,” Zhou says.
To test this theory, the researchers developed a mouse model carrying the grin2a mutation. While mice cannot experience human delusions, they can exhibit the same failure in adaptive decision-making. In a controlled experiment, mice were given a choice between two levers for a milk reward: one that was “low-reward” (requiring six presses for one drop) and one that was “high-reward” (three drops per press).
Initially, all mice chose the high-reward lever. However, the researchers gradually increased the effort required for that lever. Healthy mice quickly noticed the change and switched to the easier, low-reward option once the values became equal. The grin2a mutant mice, however, struggled to adapt. They continued to switch back and forth and delayed committing to the more efficient choice, demonstrating a significant lag in updating their behavior based on new evidence.
Mapping the Circuitry of Decision-Making
The team used functional ultrasound imaging and electrical recordings to find exactly where this breakdown was occurring. They identified the mediodorsal thalamus as the epicenter of the dysfunction.
The mediodorsal thalamus acts as a relay station, connecting to the prefrontal cortex to form a thalamocortical circuit. This circuit is the engine of executive control and decision-making. In the mutant mice, the neurons in this region failed to properly track the changing value of the rewards, leaving the animals “stuck” in an outdated behavioral pattern.
In a striking turn, the researchers found they could essentially “flip a switch” to fix the behavior. Using optogenetics—a technique that uses light to control neurons that have been genetically modified to be light-sensitive—they activated the neurons in the mediodorsal thalamus. When the light was turned on, the mutant mice began to make adaptive decisions, behaving much like the healthy control group.
Summary of Genetic and Behavioral Findings
| Feature | Neurotypical Brain | grin2a Mutation Brain |
|---|---|---|
| Belief Updating | Rapidly integrates new sensory input | Over-relies on prior beliefs |
| Decision Speed | Adaptive and efficient | Delayed and inconsistent |
| Thalamic Activity | Accurately tracks reward value | Impaired value tracking |
| Reality Alignment | High alignment with current input | Detached from current input |
The Path Toward New Treatments
While only a modest minority of schizophrenia patients possess the specific grin2a mutation, the researchers believe the discovery is universal in its implications. The dysfunction of the thalamocortical circuit may be a shared mechanism that causes cognitive impairment across a wider spectrum of patients, regardless of their specific genetic mutation.
Guoping Feng, the James W. And Patricia T. Poitras Professor in Brain and Cognitive Sciences at MIT and a senior author of the study, emphasizes the importance of this circuit. “If this circuit doesn’t work well, you cannot quickly integrate information,” Feng says. “We are quite confident this circuit is one of the mechanisms that contributes to the cognitive impairment that is a major part of the pathology of schizophrenia.”
The next phase of research involves moving beyond light-based activation toward pharmacological solutions. The team is currently working to identify specific molecular components within the mediodorsal thalamus circuit that can be targeted with drugs to restore the brain’s ability to update its reality.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The research team is now focusing on identifying drug targets within the identified circuit to determine if chemical interventions can mimic the results seen with optogenetics. Further studies are expected to explore whether these findings translate to other cognitive disorders involving reality detachment.
Do you or a loved one navigate the challenges of schizophrenia? Share your thoughts or experiences in the comments below.
